Abstract
To analyze the prevalence of hypertension-mediated organ damage (HMOD) and its relationship with enzyme activity of mutant CYP17A1 and other risk factors in patients with 17α-hydroxylase/17,20-lyase deficiency (17-OHD). A total of 68 patients with 17-OHD were recruited in the Peking Union Medical College Hospital from 2003 to 2021. The incidence of hypertension and HMOD was respectively analyzed. CYP17A1 sequencing was performed and the enzyme activity of mutant CYP17A1 was determined by analyzing the characteristics of mutation itself and the functional data reported previously. A logistic regression model was employed to analyze the factors related to HMOD and the specific damaged organs in 17-OHD patients. Sixty-five patients (95.6%) exhibited hypertension, 32 of whom were diagnosed with HMOD. c.985_987delTACinsAA (p.Y329KfsX418) (53.8%) and c.1459_1467del (p. del D487_F489) (11.4%) were the top two mutations, and no correlation was found between enzyme activity of mutant CYP17A1 and HMOD. The risk of HMOD increased by 32% for each additional year of hypertension duration, 10.2-fold for each one-grade increase in hypertension level, 2.3-fold for each grade of exacerbation of hypokalemia. Patients with 17-OHD experience a high incidence of HMOD. There was no correlation between the HMOD occurrence and enzyme activity of mutant CYP17A1. Longer duration of hypertension, more severe hypertension, and hypokalemia were independent risk factors for the occurrence of HMOD in patients with 17-OHD.
Highlights
CYP17A1 sequencing was performed for all patients and the enzyme activity of CYP17A1 mutant was determined by analyzing the characteristics of mutation itself and the functional data reported previously
The risk of hypertension-mediated organ damage (HMOD) increased by 27% for each additional year of age, 7.7-fold for each one-grade increase in hypertension level, and 1.7-fold for each grade of exacerbation of hypokalemia
There was no correlation between the HMOD occurrence and enzyme activity of mutant CYP17A1.Age, hypertension grade, and hypokalemia grade are independent risks for the occurrence of HMOD
Summary
A total of 68 patients with 17-OHD were recruited in the Peking Union Medical Hospital from 2003 to 2021.The incidence of hypertension and HMOD was analyzed. CYP17A1 sequencing was performed for all patients and the enzyme activity of CYP17A1 mutant was determined by analyzing the characteristics of mutation itself and the functional data reported previously. A logistic regression model was employed to analyze the factors related to HMOD and the specific damaged organs in patients with 17-OHD. Result(s): Sixty-five patients (95.6%) exhibited hypertension, of whom were diagnosed with HMOD in this 17-OHD cohort. Del D487_F489) (11.4%) were the top 2 mutations in this cohort, and no correlation was found between enzyme activity of mutant CYP17A1 and HMOD. Hypertension grade, and hypokalemia grade were independent risk factors for HMOD in 17-OHD patients. The risk of HMOD increased by 27% for each additional year of age, 7.7-fold for each one-grade increase in hypertension level, and 1.7-fold for each grade of exacerbation of hypokalemia
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
